Menu
Home
Latest News
Register for Updates
Links to Bioworld
About BioMarket
Contact Us
Current Online Offers
Product Categories
Biotechnology
Business Development
Chemicals
Country
Diagnostics
Drug Delivery
Drug Discovery
Drugs
Finance & Investment
Generic Drugs
Healthcare
IT & eHealth
Management
Marketing & Sales
Medical Devices
Production
Publication Series
R&D
Regulation & Policy
Therapeutics
Companies
Dental
Diseases
Line of Treatment
Biologicals
Cytotoxics
Hormone therapy
Immunomodulators
Surgery
Vaccines
Targeted
Markets
Veterinary
List All Products
Product Search
Advanced Search
Login Form
Username
Password
Remember me
Lost Password?
No account yet?
Register
Home
Info
: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.
Error
: Sorry, but the Product you've requested wasn't found!
Latest News
Expert Views: Key decision makers will shape the biosimilars landscape
Read more...
Expert Views: Is there an alternative to HRT for menopausal relief?
Read more...
Market Research Update W45 2008
Read more...
Latest Products
Stakeholder Opinions: Diabetic Renal Disease
Pipeline Insight: Orphan Diseases Myasthenia Gravis
Financial Deals Industry Tracker: Pharma & Healthcare Sep-2008
Sales Force Effectiveness
Forecast Model: Antidyslipidemics
Financial Deals Industry Tracker: Pharma & Healthcare Aug 2008
Stakeholder Insight: Osteoporosis
Pipeline and Commercial Insight: Schizophrenia
Emerging Markets Series: The Pharma Market of South Korea
Merck KGaA: PharmaVitae Profile
Les Laboratoires Servier: PharmaVitae Profile
Solvay S.A.: PharmaVitae Profile
Biogen Idec Inc.: PharmaVitae Profile
Strategic Perspectives: Antidyslipidemics Current market...
M&A trends in Pharma
Commercial Insight: Pain Market Overview
Sepracor Inc.: PharmaVitae Profile
RNA therapy: the next big thing after monoclonal antibodies?
The Top Ten Specialty Pharmaceutical Companies
The Promotional Landscape in US and Europe
Featured Products
Future Focus: Gastrointestinal Stromal Tumor
$26 250.00
$19 687.50
You Save: 25.00%
Future Focus: Myelodysplastic Syndrome
$26 250.00
$19 687.50
You Save: 25.00%
Cancer Stem Cells: Emerging Therapeutic, Diagnostic and Market
$3 350.00
$2 680.00
You Save: 20.00%
Cancer Drug Resistance 2008
$2 995.00
$2 396.00
You Save: 20.00%
Search Products
Search
Advanced Search
Product Scroller
GPCRs - OSI Pharmaceuticals
$60.00
MultiCell Technologies Inc - Competitor Report
$350.00
Novozymes Biopharma AB
$60.00
Global Pharmaceuticals
$250.00
Cooper Companies Inc - Deals and Alliances Report
$600.00
Your Cart
Show Cart
Your Cart is currently empty.
© 2008 BioMarket Group